Connor, Clark & Lunn Investment Management (CC&L)’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $13.5K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $257K | Buy |
|
|||||
|
2023
Q4 | $261K | Buy |
|
|||||
|
2023
Q3 | $312K | Buy |
|
|||||
|
2023
Q2 | $227K | Buy |
|
|||||
|
2023
Q1 | $79.6K | Sell |
|
|||||
|
2022
Q4 | $74.3K | Sell |
|
|||||
|
2022
Q3 | $78K | Buy |
|
|||||
|
2022
Q2 | $79K | Sell |
|
|||||
|
2022
Q1 | $273K | Sell |
|
|||||
|
2021
Q4 | $384K | Sell |
|
|||||
|
2021
Q3 | $671K | Sell |
|
|||||
|
2021
Q2 | $1.01M | Buy |
|
|||||
|
2021
Q1 | $1.01M | Buy |
|
|||||
|
2020
Q4 | $536K | Buy |
|
|||||
|
2020
Q3 | $861K | Sell |
|
|||||
|
2020
Q2 | $1.4M | Buy |
|
|||||
|
2020
Q1 | $473K | Buy |
|